✦ LIBER ✦

Intermediate-Risk Prostate Cancer Treated With Definitive Low-dose-rate Brachytherapy

✍ Scribed by Ester, E.C.; Wang, X.; Vernon, M.R.; Olson, N.J.; Shanley, R.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gleason Score 7 Prostate Adenocarcinoma

✍ Ester, Elizabeth C.; Dang, Phuong-Di D.; Wang, Xin; Lynch, Joseph G.; Shanley, R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Radiation Dose Predicts for Biochemical

✍ Alice Y. Ho; Ryan J. Burri; Jamie A. Cesaretti; Nelson N. Stone; Richard G. Stoc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Long-term Outcome Analysis for Low/Inter

✍ H. Ye; A. Martinez; M. Wallace; J. Dilworth; C. Mitchell; K. Marvin; D. Krauss; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

229 oral CLINICAL OUTCOMES COMPARISON FO

✍ A. Martinez; M. Ghilezan; H. Ye; P. Chen; D. Krauss; J. Dilworth; M. Wallace; G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Sector analysis of dosimetry of prostate

✍ Nasser, Nicola J.; Wang, Yinkun; Borg, Jette; Saibishkumar, Elantholi P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 651 KB

The Cancer of the Prostate Risk Assessme

✍ Krishnan, Vimal; Delouya, Guila; Bahary, Jean-Paul; Larrivée, Sandra; Taussky, D 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB